QUIZ: Is the FluMist Nasal Vaccine Recommended This Year?
MD /alert
June 23, 2020
For the 2019-2020 influenza season, the Centers for Disease Control and American Academy of Pediatrics deemed FluMist, the nasal flu vaccine spray, safe and is recommended for patients 2 through 49 years of age.
This is especially beneficial for pediatric patients who are hesitant about needles, as well as children who would not otherwise receive the vaccine.
MORE FROMVaccines Advanced Learning Center
No Added Heart And Lung Benefit Of High-Dose Flu Vaccine
December 20, 2020
IDSA Updates Status of Vaccinations Among Adolescents
December 17, 2020
Plant-Derived Influenza Vaccine Effective, Safe in Adults
December 16, 2020
FDA Approves First Covid-19, Flu Test With Home-collected Samples
December 14, 2020
GSK Says Flu Shot Shortage Not Linked To Covid-19 Vaccine Ramp Up
November 17, 2020
Assessing Challenges of Potential COVID-19 Vaccines
November 05, 2020
Facebook Will Ban Ads Discouraging People From Getting Vaccines
October 14, 2020
Addressing Vaccine Confidence During COVID-19 Pandemic
October 06, 2020
FDA Clears Clinical Trial for Universal Anti-Viral Vaccine
September 16, 2020
Manufacturer Announces New Trial for 5-in-1 Meningitis Vaccine
September 09, 2020
FDA Approves MenQuadfi Meningococcal Vaccine
August 14, 2020
COVID-19 Vaccine Just One Part of Advancing Research
August 11, 2020
Vaccine Safety Affirmed in Review of FDA Approvals
July 29, 2020
U.S. FDA Issues Guidance for COVID-19 Vaccine Approval
July 07, 2020.jpg)
Who Should Receive the Herpes Zoster Vaccine?
May 22, 2020
.jpg)
.jpg)
.jpg)